Clotizolam
![]()  | |
| Legal status | |
|---|---|
| Legal status | 
  | 
| Identifiers | |
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C15H10Cl2N4S | 
| Molar mass | 349.23 g·mol−1 | 
| 3D model (JSmol) | |
| Melting point | 205 °C (401 °F) | 
  | |
  | |
Clotizolam (Ro11-1465) is a thienotriazolodiazepine derivative first invented in the 1970s, which in more recent years has been sold as a designer drug. As with other related thienotriazolodiazepines, it produces sedative, anxiolytic, anticonvulsant and muscle relaxant effects,[1] and also acts as an inhibitor of platelet-activating factor (PAF).[2]
See also
References
- ^ US 4155913, Hellerbach J, Zeller P, Binder D, Hromatka O, "Thienotriazolodiazepine derivatives", issued 22 May 1979, assigned to Hoffmann La Roche Inc.
 - ^ Tahara T, Mikashima H, Terasawa M, Maruyama Y (May 1987). "PAF antagonistic activity of some thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines". Chemical & Pharmaceutical Bulletin. 35 (5): 2119–21. doi:10.1248/cpb.35.2119. PMID 3664818. S2CID 27564672.
 
| Alcohols | |
|---|---|
| Barbiturates | 
  | 
| Benzodiazepines | 
  | 
| Carbamates | |
| Flavonoids | 
  | 
| Imidazoles | |
| Kava constituents | 
  | 
| Monoureides | 
  | 
| Neuroactive steroids | 
  | 
| Nonbenzodiazepines | |
| Phenols | |
| Piperidinediones | |
| Pyrazolopyridines | |
| Quinazolinones | |
| Volatiles/gases | 
  | 
| Others/unsorted | 
 
  | 
See also: Receptor/signaling modulators • GABA receptor modulators • GABA metabolism/transport modulators  | |
 
     This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files. 
 